Gottlieb seeks new comparative approval standard for opioids
With just a week left before he departs from the FDA, Commissioner Scott Gottlieb on Thursday told the Senate Appropriations Committee that his agency is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
